These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26961797)

  • 1. Generation of a novel, multi-stage, progressive, and transplantable model of plasma cell neoplasms.
    Asai T; Hatlen MA; Lossos C; Ndiaye-Lobry D; Deblasio A; Murata K; Fleisher M; Cortizas EM; Verdun RE; Petrini J; Nimer SD
    Sci Rep; 2016 Mar; 6():22760. PubMed ID: 26961797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Rad50S allele promotes ATM-dependent DNA damage responses and suppresses ATM deficiency: implications for the Mre11 complex as a DNA damage sensor.
    Morales M; Theunissen JW; Kim CF; Kitagawa R; Kastan MB; Petrini JH
    Genes Dev; 2005 Dec; 19(24):3043-54. PubMed ID: 16357220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The polycomb group protein enhancer of zeste homolog 2 (EZH 2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype.
    Croonquist PA; Van Ness B
    Oncogene; 2005 Sep; 24(41):6269-80. PubMed ID: 16007202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
    Kim D; Park CY; Medeiros BC; Weissman IL
    Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational Landscape and Antiproliferative Functions of ELF Transcription Factors in Human Cancer.
    Ando M; Kawazu M; Ueno T; Koinuma D; Ando K; Koya J; Kataoka K; Yasuda T; Yamaguchi H; Fukumura K; Yamato A; Soda M; Sai E; Yamashita Y; Asakage T; Miyazaki Y; Kurokawa M; Miyazono K; Nimer SD; Yamasoba T; Mano H
    Cancer Res; 2016 Apr; 76(7):1814-24. PubMed ID: 26921333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer predisposition and hematopoietic failure in Rad50(S/S) mice.
    Bender CF; Sikes ML; Sullivan R; Huye LE; Le Beau MM; Roth DB; Mirzoeva OK; Oltz EM; Petrini JH
    Genes Dev; 2002 Sep; 16(17):2237-51. PubMed ID: 12208847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of c-myc promoter-binding protein and X-box binding protein 1 as interleukin-6 target genes in human multiple myeloma cells.
    Wen XY; Stewart AK; Sooknanan RR; Henderson G; Hawley TS; Reimold AM; Glimcher LH; Baumann H; Malek LT; Hawley RG
    Int J Oncol; 1999 Jul; 15(1):173-8. PubMed ID: 10375612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor promoting properties of the ETS protein MEF in ovarian cancer.
    Yao JJ; Liu Y; Lacorazza HD; Soslow RA; Scandura JM; Nimer SD; Hedvat CV
    Oncogene; 2007 Jun; 26(27):4032-7. PubMed ID: 17213815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular mechanism of oncogenesis and progression in human myeloma].
    Kawano MM; Otsuyama K
    Nihon Rinsho; 2007 Dec; 65(12):2187-93. PubMed ID: 18069259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors.
    Pilarski LM; Belch AR
    Clin Cancer Res; 2002 Oct; 8(10):3198-204. PubMed ID: 12374689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential maturation stages of monoclonal B lineage cells from blood, spleen, lymph node, and bone marrow from a terminal myeloma patient.
    Jensen GS; Mant MJ; Pilarski LM
    Am J Hematol; 1992 Nov; 41(3):199-208. PubMed ID: 1384318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ETS transcription factor MEF is a candidate tumor suppressor gene on the X chromosome.
    Seki Y; Suico MA; Uto A; Hisatsune A; Shuto T; Isohama Y; Kai H
    Cancer Res; 2002 Nov; 62(22):6579-86. PubMed ID: 12438253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice.
    Pilarski LM; Seeberger K; Coupland RW; Eshpeter A; Keats JJ; Taylor BJ; Belch AR
    Exp Hematol; 2002 Mar; 30(3):221-8. PubMed ID: 11882359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells.
    Lacorazza HD; Yamada T; Liu Y; Miyata Y; Sivina M; Nunes J; Nimer SD
    Cancer Cell; 2006 Mar; 9(3):175-87. PubMed ID: 16530702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles and regulations of the ETS transcription factor ELF4/MEF.
    Suico MA; Shuto T; Kai H
    J Mol Cell Biol; 2017 Jun; 9(3):168-177. PubMed ID: 27932483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis.
    Carrasco DR; Sukhdeo K; Protopopova M; Sinha R; Enos M; Carrasco DE; Zheng M; Mani M; Henderson J; Pinkus GS; Munshi N; Horner J; Ivanova EV; Protopopov A; Anderson KC; Tonon G; DePinho RA
    Cancer Cell; 2007 Apr; 11(4):349-60. PubMed ID: 17418411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythroblast apoptosis and microenvironmental iron restriction trigger anemia in the VK*MYC model of multiple myeloma.
    Bordini J; Bertilaccio MT; Ponzoni M; Fermo I; Chesi M; Bergsagel PL; Camaschella C; Campanella A
    Haematologica; 2015 Jun; 100(6):834-841. PubMed ID: 25715406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GP130 activation induces myeloma and collaborates with MYC.
    Dechow T; Steidle S; Götze KS; Rudelius M; Behnke K; Pechloff K; Kratzat S; Bullinger L; Fend F; Soberon V; Mitova N; Li Z; Thaler M; Bauer J; Pietschmann E; Albers C; Grundler R; Schmidt-Supprian M; Ruland J; Peschel C; Duyster J; Rose-John S; Bassermann F; Keller U
    J Clin Invest; 2014 Dec; 124(12):5263-74. PubMed ID: 25384216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells.
    Das DS; Das A; Ray A; Song Y; Samur MK; Munshi NC; Chauhan D; Anderson KC
    Clin Cancer Res; 2017 Aug; 23(15):4280-4289. PubMed ID: 28270494
    [No Abstract]   [Full Text] [Related]  

  • 20. The oncoprotein phenotype of plasma cells from patients with multiple myeloma.
    Brown RD; Pope B; Luo XF; Gibson J; Joshua D
    Leuk Lymphoma; 1994 Dec; 16(1-2):147-56. PubMed ID: 7696921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.